BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Business

  Anavex Life Sciences Corp. Appoints Dr. Jeffrey Cummings to Its Scientific Advisory Board

  March 1, 2011

   · 

  6 min read
• Business

  Idenix Pharmaceuticals, Inc. Reports Fourth Quarter and Year End 2010 Financial Results

  March 1, 2011

   · 

  8 min read
• Biotech Bay

  Epeius Biotechnologies Corporation’s REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA

  March 1, 2011

   · 

  2 min read
• Business

  VIVUS, Inc. Reports 2010 Fourth Quarter and Full-Year Financial Results

  March 1, 2011

   · 

  8 min read
• Stereotaxis, Inc. Reports 2010 Financial Results, Provides 2011 Financial Outlook

  March 1, 2011

   · 

  1 min read
• BioMidwest

  Perrigo Company to Present at the Citi 2011 Global Health Care Conference

  March 1, 2011

   · 

  1 min read
• Genetown

  Repligen Corporation to Present at the Cowen and Company 31st Annual Healthcare Conference

  March 1, 2011

   · 

  1 min read
• Provectus Pharmaceuticals Inc. Updates Shareholders with Year in Review and Discusses Clinical Development Plans

  March 1, 2011

   · 

  1 min read
• BioForest

  Iverson Genetic Diagnostics Release: WARFARIN Study Launched to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin

  March 1, 2011

   · 

  4 min read
• Drug Development

  Geron Corporation Announces Preclinical Study Data of GRNCM1

  March 1, 2011

   · 

  1 min read